We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

ProBioGen Signs Therapeutic Protein Process Development Contract with Virdante Pharmaceuticals

News   Apr 28, 2010

 
ProBioGen Signs Therapeutic Protein Process Development Contract with Virdante Pharmaceuticals
 
 
Advertisement
 

RELATED ARTICLES

Ribosomes Undergo a “Molting” Process, Shedding Their Layers

News

Maturation of the ribosome is a complex operation. Work by Ludwig-Maximilians-Universitaet (LMU) researchers now shows that the 90S precursor of the small 40S subunit undergoes a 'molting' process, during which it progressively discards its outermost components.

READ MORE

A Real-Time Look at How Viruses Attack at the Single-Cell Level

News

A collaboration is on a mission to understand, in visual detail and with mathematical precision, all aspects of viral attack strategies, including how viruses invade host cell protein-making machinery.

READ MORE

Ultrapotent Compound Could Help Combat C. difficile

News

Scientists from Purdue University have advanced novel compounds that they have designed to help treat patients with Clostridioides difficile.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE